Beverly Koller
12Patents
6h-index
12Co-inventors
63Inventor score
Filing activity: Sep 4, 1985 → Nov 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5413923A | Homologous recombination for universal donor cells and chimeric mammalian hosts | Human Necessities | 218 | Expired |
| US5574205A | Homologous recombination for universal donor cells and chimeric mammalian hosts | Human Necessities | 87 | Expired |
| US5416260A | Homologous recombination for universal donor cells and chimeric mammalian hosts | Human Necessities | 62 | Expired |
| US6514752B1 | Homologous recombination for universal donor cells and chimeric mammalian hosts | Human Necessities | 44 | Expired |
| US6139835A | Homologous recombination for allogeneic donor cells | Human Necessities | 42 | Expired |
| US4835098A | Characterization of HLA alleles with locus-specific DNA probes | Emerging Cross-Sectional Technologies | 22 | Expired |
| US10016483B2 | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors | Human Necessities | 4 | Active |
| US9572863B2 | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors | Human Necessities | 2 | Active |
| US10857202B2 | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors | Human Necessities | 1 | Active |
| US10398754B2 | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors | Human Necessities | 1 | Active |
| US6677501B2 | P2X7 receptor-deficient mice and uses thereof | Human Necessities | 0 | Expired |
| US11382951B2 | Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.